Cargando…

Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United States

OBJECTIVE: To compare temporal trends in clinical and health care resource utilization (HRU) outcomes in people with refractory and nonrefractory generalized myasthenia gravis (gMG). METHODS: A retrospective analysis of data from adults with gMG in the Myasthenia Gravis Foundation of America Patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harris, Linda, Allman, Phillip H., Sheffield, Reinee, Cutter, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Clinical Neuromuscular Disease 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447171/ https://www.ncbi.nlm.nih.gov/pubmed/32833720 http://dx.doi.org/10.1097/CND.0000000000000301

Ejemplares similares

Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis
por: Harris, Linda, et al.
Publicado: (2019)

Examining the Impact of Refractory Myasthenia Gravis on Healthcare Resource Utilization in the United States: Analysis of a Myasthenia Gravis Foundation of America Patient Registry Sample
por: Xin, Haichang, et al.
Publicado: (2019)

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life
por: Boscoe, Audra N., et al.
Publicado: (2019)

Understanding the burden of refractory myasthenia gravis
por: Schneider-Gold, Christiane, et al.
Publicado: (2019)

A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
por: Harris, Linda, et al.
Publicado: (2022)

Cross‐sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment
por: Cutter, Gary, et al.
Publicado: (2019)

Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Refractory generalized myasthenia gravis with myasthenic incomplete ophthalmoplegia successfully treated with eculizumab
por: Weidmayer, Sara L., et al.
Publicado: (2023)

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
por: Oyama, Munenori, et al.
Publicado: (2020)

Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study
por: McPherson, Tarrant, et al.
Publicado: (2020)

Clinical Characteristics of Refractory Myasthenia Gravis Patients
por: Suh, Joome, et al.
Publicado: (2013)

Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
por: Phillips, Glenn, et al.
Publicado: (2022)

Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses
por: Howard, James F., et al.
Publicado: (2021)

Comparison of Clinical Manifestations between Patients with Ocular Myasthenia Gravis and Generalized Myasthenia Gravis
por: Roh, Hyun Seok, et al.
Publicado: (2011)

Frequency and clinical features of treatment-refractory myasthenia gravis
por: Rath, Jakob, et al.
Publicado: (2019)

One‐year follow‐up of disease burden and medication changes in patients with myasthenia gravis: From the MG Patient Registry
por: Lee, Ikjae, et al.
Publicado: (2022)

Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021)

Burden of disease in myasthenia gravis: taking the patient’s perspective
por: Lehnerer, Sophie, et al.
Publicado: (2021)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Eculizumab: A Review in Generalized Myasthenia Gravis
por: Dhillon, Sohita
Publicado: (2018)

Sotalol‐induced generalized and ocular myasthenia gravis
por: Sharifkazemi, Mohammadbagher, et al.
Publicado: (2019)

Association of Smoking and Generalized Manifestations of Myasthenia Gravis
por: Miyazaki, Yusei, et al.
Publicado: (2021)

Refractory myasthenia gravis – clinical profile, comorbidities and response to rituximab
por: Sudulagunta, Sreenivasa Rao, et al.
Publicado: (2016)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subxiphoid completion thymectomy for refractory non-thymomatous myasthenia gravis
por: Ambrogi, Vincenzo, et al.
Publicado: (2020)

Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
por: Cortés‐Vicente, Elena, et al.
Publicado: (2022)

Clinical Experience with Eculizumab in Treatment-Refractory Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
por: Katyal, Nakul, et al.
Publicado: (2021)

Correction to: Burden of disease in myasthenia gravis: taking the patient’s perspective
por: Lehnerer, Sophie, et al.
Publicado: (2022)

The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan
por: Herr, Keira Joann, et al.
Publicado: (2023)

The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
por: Hughes, Tom, et al.
Publicado: (2023)

Addressing Outcome Measure Variability in Myasthenia Gravis Clinical Trials
por: Guptill, Jeffrey T., et al.
Publicado: (2023)

Gender differences in quality of life among patients with myasthenia gravis in China
por: Dong, Dong, et al.
Publicado: (2020)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
por: Mantegazza, Renato, et al.
Publicado: (2018)

Polymorphisms in drug metabolism genes predict the risk of refractory myasthenia gravis
por: Zhang, Qing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_461d78ghv2vp8ta6m52vgpphvh